Antipyretic Therapy in Critically Ill Septic Patients: A Systematic Review and Meta-Analysis

Overview

Journal Crit Care Med

Specialties Critical Care
Emergency Medicine

Date 2017 Feb 22

PMID 28221185

Citations 24

Authors

Anne M Drewry

Enyo A Ablordeppey

Ellen T Murray

Carolyn R T Stoll

Sonya R Izadi

Catherine M Dalton

Angela C Hardi

Susan A Fowler

Brian M Fuller

Graham A Colditz

Affiliations

Soon will be listed here.

Abstract

Objective: This meta-analysis aimed to examine the impact of antipyretic therapy on mortality in critically ill septic adults.

Data Sources: Literature searches were implemented in Ovid Medline, Embase, Scopus, Cumulative Index of Nursing and Allied Health Literature, Cochrane Central Register of Controlled Trials, NHS Economic Evaluation Database, and ClinicalTrials.gov through February 2016.

Study Selection: Inclusion criteria were observational or randomized studies of septic patients, evaluation of antipyretic treatment, mortality reported, and English-language version available. Studies were excluded if they enrolled pediatric patients, patients with neurologic injury, or healthy volunteers. Criteria were applied by two independent reviewers.

Data Extraction: Two reviewers independently extracted data and evaluated methodologic quality. Outcomes included mortality, frequency of shock reversal, acquisition of nosocomial infections, and changes in body temperature, heart rate, and minute ventilation. Randomized and observational studies were analyzed separately.

Data Synthesis: Eight randomized studies (1,507 patients) and eight observational studies (17,432 patients) were analyzed. Antipyretic therapy did not reduce 28-day/hospital mortality in the randomized studies (relative risk, 0.93; 95% CI, 0.77-1.13; I = 0.0%) or observational studies (odds ratio, 0.90; 95% CI, 0.54-1.51; I = 76.1%). Shock reversal (relative risk, 1.13; 95% CI, 0.68-1.90; I = 51.6%) and acquisition of nosocomial infections (relative risk, 1.13; 95% CI, 0.61-2.09; I = 61.0%) were also unchanged. Antipyretic therapy decreased body temperature (mean difference, -0.38°C; 95% CI, -0.63 to -0.13; I = 84.0%), but not heart rate or minute ventilation.

Conclusions: Antipyretic treatment does not significantly improve 28-day/hospital mortality in adult patients with sepsis.

Citing Articles

Long-term health effects of antipyretic drug use in the aging population: a systematic review.

Mahesh S, van der Werf E, Mallappa M, Vithoulkas G, Lai N J Med Life. 2024; 17(9):830-839.

PMID: 39628966 PMC: 11611054. DOI: 10.25122/jml-2024-0081.

Postoperative fever and clinical outcomes after endoscopic surgery for spontaneous intracerebral hemorrhage: a retrospective database study.

Liu S, Zhang Y, Su S, Ren J, Long J, Cao S BMC Neurol. 2024; 24(1):392.

PMID: 39407147 PMC: 11476804. DOI: 10.1186/s12883-024-03898-4.

The Nonlinear Relationship Between Temperature and Prognosis in Sepsis-induced Coagulopathy Patients: A Retrospective Cohort Study from MIMIC-IV Database.

Chen G, Zhou T, Xu J, Hu Q, Jiang J, Xu W West J Emerg Med. 2024; 25(5):697-707.

PMID: 39319800 PMC: 11418858. DOI: 10.5811/westjem.18589.

Construction and evaluation of shortterm and longterm mortality risk prediction model for patients with sepsis based on MIMICIV database.

Yan D, Xie X, Fu X, Xu D, Li N, Yao R Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2024; 49(2):256-265.

PMID: 38755721 PMC: 11103058. DOI: 10.11817/j.issn.1672-7347.2024.230390.

Protocol for fever control using external cooling in mechanically ventilated patients with septic shock: SEPSISCOOL II randomised controlled trial.

Guenegou-Arnoux A, Murris J, Bechet S, Jung C, Auchabie J, Dupeyrat J BMJ Open. 2024; 14(1):e069430.

PMID: 38286691 PMC: 10826574. DOI: 10.1136/bmjopen-2022-069430.

References

Jiang Q, Cross A, Singh I, Chen T, Viscardi R, Hasday J . Febrile core temperature is essential for optimal host defense in bacterial peritonitis. Infect Immun. 2000; 68(3):1265-70. PMC: 97277. DOI: 10.1128/IAI.68.3.1265-1270.2000. View

Young P, Saxena M, Beasley R, Bellomo R, Bailey M, Pilcher D . Early peak temperature and mortality in critically ill patients with or without infection. Intensive Care Med. 2012; . DOI: 10.1007/s00134-012-2478-3. View

Zhang Z . Antipyretic therapy in critically ill patients with established sepsis: a trial sequential analysis. PLoS One. 2015; 10(2):e0117279. PMC: 4339198. DOI: 10.1371/journal.pone.0117279. View

Langan D, Higgins J, Gregory W, Sutton A . Graphical augmentations to the funnel plot assess the impact of additional evidence on a meta-analysis. J Clin Epidemiol. 2012; 65(5):511-9. DOI: 10.1016/j.jclinepi.2011.10.009. View

Kushimoto S, Gando S, Saitoh D, Mayumi T, Ogura H, Fujishima S . The impact of body temperature abnormalities on the disease severity and outcome in patients with severe sepsis: an analysis from a multicenter, prospective survey of severe sepsis. Crit Care. 2013; 17(6):R271. PMC: 4057086. DOI: 10.1186/cc13106. View

Bernard G, Reines H, Halushka P, Higgins S, Metz C, Swindell B . Prostacyclin and thromboxane A2 formation is increased in human sepsis syndrome. Effects of cyclooxygenase inhibition. Am Rev Respir Dis. 1991; 144(5):1095-101. DOI: 10.1164/ajrccm/144.5.1095. View

Mackowiak P, Cohen R . Effects of temperature on antimicrobial susceptibility of bacteria. J Infect Dis. 1982; 145(4):550-3. DOI: 10.1093/infdis/145.4.550. View

Chu C, Tian S, Ren G, Zhang Y, Zhang L, Liu G . Occurrence of temperature-sensitive influenza A viruses in nature. J Virol. 1982; 41(2):353-9. PMC: 256765. DOI: 10.1128/JVI.41.2.353-359.1982. View

Harris P, Taylor R, Thielke R, Payne J, Gonzalez N, Conde J . Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2008; 42(2):377-81. PMC: 2700030. DOI: 10.1016/j.jbi.2008.08.010. View

10.

DerSimonian R, Laird N . Meta-analysis in clinical trials. Control Clin Trials. 1986; 7(3):177-88. DOI: 10.1016/0197-2456(86)90046-2. View

11.

Selladurai S, Eastwood G, Bailey M, Bellomo R . Paracetamol therapy for septic critically ill patients: a retrospective observational study. Crit Care Resusc. 2011; 13(3):181-6. View

12.

Niven D, Stelfox H, Leger C, Kubes P, Laupland K . Assessment of the safety and feasibility of administering antipyretic therapy in critically ill adults: a pilot randomized clinical trial. J Crit Care. 2012; 28(3):296-302. DOI: 10.1016/j.jcrc.2012.08.015. View

13.

Lee C, Zhong L, Mace T, Repasky E . Elevation in body temperature to fever range enhances and prolongs subsequent responsiveness of macrophages to endotoxin challenge. PLoS One. 2012; 7(1):e30077. PMC: 3254634. DOI: 10.1371/journal.pone.0030077. View

14.

Niven D, Laupland K, Tabah A, Vesin A, Rello J, Koulenti D . Diagnosis and management of temperature abnormality in ICUs: a EUROBACT investigators' survey. Crit Care. 2013; 17(6):R289. PMC: 4057370. DOI: 10.1186/cc13153. View

15.

Frankenfield D, Smith Jr J, Cooney R, Blosser S, Sarson G . Relative association of fever and injury with hypermetabolism in critically ill patients. Injury. 1998; 28(9-10):617-21. DOI: 10.1016/s0020-1383(97)00117-4. View

16.

Janz D, Bastarache J, Peterson J, Sills G, Wickersham N, May A . Association between cell-free hemoglobin, acetaminophen, and mortality in patients with sepsis: an observational study. Crit Care Med. 2013; 41(3):784-90. PMC: 3578977. DOI: 10.1097/CCM.0b013e3182741a54. View

17.

Wan X, Wang W, Liu J, Tong T . Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014; 14:135. PMC: 4383202. DOI: 10.1186/1471-2288-14-135. View

18.

Bernard G, Wheeler A, Russell J, Schein R, Summer W, Steinberg K . The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group. N Engl J Med. 1997; 336(13):912-8. DOI: 10.1056/NEJM199703273361303. View

19.

Niven D, Stelfox H, Laupland K . Antipyretic therapy in febrile critically ill adults: A systematic review and meta-analysis. J Crit Care. 2012; 28(3):303-10. DOI: 10.1016/j.jcrc.2012.09.009. View

20.

Mohr N, Doerschug K . Point: Should antipyretic therapy be given routinely to febrile patients in septic shock? Yes. Chest. 2013; 144(4):1096-1098. DOI: 10.1378/chest.13-0916. View